黄金微针治疗中度面部痤疮对痤疮严重程度的影响
DOI:
CSTR:
作者:
作者单位:

张家港市第一人民医院皮肤科 215600

作者简介:

通讯作者:

中图分类号:

基金项目:


Observation on the Clinical Efficacy of Single-Needle Radiofrequency in the Treatment of Moderate to Severe Facial Acne
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察单针射频联合口服药物治疗中重度面部痤疮的疗效和安全性。方法:本研究纳入2022年3月至2023年3月期间张家港市第一人民医院皮肤科收治的40例中重度面部痤疮患者,按治疗方式分为试验组和对照组,每组20例。对照组采用罗红霉素联合维胺酯胶囊治疗,试验组采用单针射频联合罗红霉素联合维胺酯胶囊治疗。治疗8周后,比较两组临床疗效、痤疮严重程度、全球美学改善量表(GAIS)评分和不良反应。结果:治疗8周后,试验组的总有效率为90%,显著高于对照组的60%(P<0.05);治疗后两组患者痤疮严重程度评分均下降,且试验组评分显著低于对照组(P<0.05);两组患者面部痤疮均有改善,试验组GAIS评分显著高于对照组(P<0.05);治疗期间,试验组的不良反应总发生率高于对照组,但差异无统计学意义(P>0.05)。结论:单针射频联合罗红霉素与维胺酯胶囊治疗中重度面部痤疮疗效优于单纯口服药物治疗,可显著改善患者痤疮病情,促进皮损消退,有效改善患者面部美观,且不良反应轻微、安全性高,具有重要的临床推广应用价值。

    Abstract:

    Objective:? To observe the efficacy and safety of single-needle radiofrequency combined with oral medication in the treatment of moderate to severe facial acne. Methods:? 40 patients with moderate to severe facial acne admitted to the Department of Dermatology, Zhangjiagang First People’s Hospital from March 2022 to March 2023 were enrolled and divided into an experimental group and a control group according to treatment methods, with 20 cases in each group. The control group was treated with roxithromycin combined with viaminate capsules, while the experimental group received single?needle radiofrequency plus roxithromycin and viaminate capsules. Results: After 8 weeks of treatment, the total effective rate of the study group (90%) was significantly higher than that of the control group (60%, P<0.05). The acne severity score of the study group was significantly lower, and the GAIS score was significantly higher than those of the control group (both P<0.05). The total incidence of adverse reactions in the study group was higher but with no statistical difference (P>0.05). Conclusion: Single-needle radiofrequency combined with oral medications is more effective than oral medications alone for moderate to severe facial acne, with mild adverse reactions and high safety, worthy of clinical promotion.

    参考文献
    相似文献
    引证文献
引用本文
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2026-04-14
  • 最后修改日期:2026-07-20
  • 录用日期:2026-07-23
  • 在线发布日期:
  • 出版日期:
文章二维码